Dr. Gérard LEFAURE
C.E.O
ABOUT US
Transforming a surgical frustration into a major medical innovation.
A team of academic researchers, surgeons, and engineers united by the drive to rethink vascular pathologies.
An implantable medical device dedicated to a single clinical indication.
A simple, precise, easy-to-use, and effective delivery system.
THIRTY YEARS OF PRACTICE REVEALED A CLEAR TRUTH: IT WAS TIME TO RETHINK ENDOVASCULAR DEVICES.
A STORY BORN FROM
CLINICAL EXPERIENCE
DESIGNING A DEVICE SPECIFICALLY FOR VEINS, RATHER THAN ADAPTING FROM ARTERIES.
ID NEST Medical was born from the experience of a vascular surgeon faced with the limitations of traditional devices. For over thirty years, he witnessed the use of devices for conditions for which they were not specifically designed.
This led to the creation of the T-Stent, an innovative and patented technology capable of restoring natural venous flow while ensuring lasting stability.
OUR MISSION IS CLEAR
Sustainably improving the management of chronic
venous pathologies worldwide.
WE DEVELOP MEDICAL DEVICES:
SAFER AND MORE EFFECTIVE FOR PATIENTS
SIMPLER AND EASIER TO USE FOR PRACTITIONERS
MORE COST-EFFECTIVE IN THE LONG TERM FOR HEALTHCARE SYSTEMS
With each innovation, ID NEST Medical aims to address a real, specific, and unique medical need in rapidly growing global markets.
OUR VALUES
RESPONSIBLE INNOVATION
Each technology is conceived for its clinical relevance before its technical performance.
SCIENTIFIC RIGOR
Our research is based on preclinical and clinical validations conducted with renowned institutions.
REGULATORY READINESS
Comprehensive design documentation strictly complying with ISO 13485, ISO 14971, and ISO 10993 standards.
INTERNATIONAL COLLABORATION
Doctors, engineers, researchers, and investors moving forward together toward a single goal: significantly improving patient comfort and quality of life.
A MULTIDISCIPLINARY TEAM
Every team member shares a common conviction: medical innovation must originate from clinical practice and return to serve it.
Pr Nabil CHAKFE
Founder
Pr Nabil CHAKFE
Founder
Professor of Vascular Surgery University Hospital of Strasbourg, France
President of the European Society for Vascular Surgery
Authored over 350 scientific publications
Expert in endovascular prostheses
William WIECEK
C.O.O.
William WIECEK
C.O.O.
30+ years of experience in the medical device industry.
Former General Manager of ASPIDE Medical, overseeing R&D and regulatory affairs for implantable devices.
Expert in CE marking, ISO 13485, FDA compliance, and global medical device commercialization.
Led multiple product launches in Europe, the US, Canada, Japan, and Brazil.
Antoine DURET
R&D Manager
Antoine DURET
R&D Manager
Mechanical engineer with deep expertise in medical device design and intelligent healthcare technologies.
Previously led mechanical architecture at Siemens and developed patented innovations at HAGER Group.
Specializes in biomechanics, product development, and industrialization of medical devices.
Dr Philippe NICOLINI
Doctor
Dr Olivier HARTUNG
Doctor
Pr Fabien THAVEAU
Profesor
THE ID NEST MEDICAL TEAM BRINGS TOGETHER:
- world-renowned vascular surgeons,
- biomedical engineers specializing in self-expanding implants,
- experts in regulatory affairs and clinical development,
- seasoned entrepreneurs in the medical device sector.
This diversity of profiles ensures both a grounded clinical vision and rigorous industrial execution.
INTERNATIONAL SCIENTIFIC COMMITTEE
The ID NEST Scientific Committee brings together top-tier specialists from leading institutions.
THEIR ROLE :
- guide research and clinical trials,
- validate scientific protocols,
- ensure ethical compliance and the medical relevance of the device.
This governance ensures international academic recognition and establishes ID NEST’s unquestionable scientific legitimacy.
TOWARDS A NEW ERA OF VENOUS TREATMENT
Through the convergence of medical expertise, engineering, and clinical research, ID NEST Medical is paving the way for a new generation of endovascular solutions.
Each innovation aims to make treatments more human-centric, accessible, and sustainable. This is how we transform science into tangible progress for patients.
